Results 71 to 80 of about 470,101 (105)

Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine. [PDF]

Eur Heart J
Gonzalez-Lopez E, Maurer MS, Garcia-Pavia P.   +2 more
europepmc   +1 more source

Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine. [PDF]

Pharmaceutics
Srivastav AK, Mishra MK, Lillard JW, Singh R.   +3 more
europepmc   +1 more source

Engineering Stimuli-Responsive Materials for Precision Medicine. [PDF]

Small
Zheng R, Yu C, Yao D, Cai M, Zhang L, Ye F, Huang X.   +6 more
europepmc   +1 more source

Development of a robust BH3 drug toolkit for precision medicine in hematologic malignancies. [PDF]

Theranostics
Jacquier V, Romero A, Molinaro C, Somayaji R, Abouladze M, Gadacha OK, Ovejero S, de Boussac H, Gabellier L, Davids MS, Moreaux J, Herbaux C.   +11 more
europepmc   +1 more source

Microfluidic Nanoparticle Separation for Precision Medicine. [PDF]

Adv Sci (Weinh)
Lan Z, Chen R, Zou D, Zhao CX.
europepmc   +1 more source

Correction to: Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine. [PDF]

Eur Heart J
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Preparing for Precision Medicine

New England Journal of Medicine, 2012
Precision medicine uses clinicopathological indexes and molecular profiling to create diagnostic, prognostic, and therapeutic strategies tailored to the patient. Its success depends on establishing frameworks for regulating, compiling, and interpreting key information.
Jeremy K. Nicholson, Ara Darzi, Reza Mirnezami   +2 more
openaire   +3 more sources